{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:04Z","timestamp":1756902124776,"version":"3.44.0"},"reference-count":9,"publisher":"The Pediatric Pharmacy Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:p>A healthy 5-year-old girl developed myalgia and an elevated creatine kinase concentration after 4 days of normal doses of clarithromycin. Myalgias resolved and creatine kinase values returned to normal following discontinuation of clarithromycin. No other precipitating factors or interacting drugs were identified; hence, clarithromycin was suspected as the cause of the rhabdomyolysis.<\/jats:p>","DOI":"10.5863\/1551-6776-16.3.216","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:14:52Z","timestamp":1603829692000},"page":"216-217","source":"Crossref","is-referenced-by-count":1,"title":["Rhabdomyolysis Following a Short Course of Clarythromycin"],"prefix":"10.5863","volume":"16","author":[{"given":"Anna M.","family":"Schor","sequence":"first","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic States, Gaithersburg, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Hellerstein","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic States, Gaithersburg, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"9","key":"2020102716100116100_i1551-6776-16-3-216-b01","first-page":"272","article-title":"Rhabdomyolysis: a review of the literature","volume":"67","author":"Khan","year":"2009;","journal-title":"Neth J Med"},{"issue":"1","key":"2020102716100116100_i1551-6776-16-3-216-b02","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009;","journal-title":"N Engl J Med"},{"issue":"5","key":"2020102716100116100_i1551-6776-16-3-216-b03","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1542\/peds.2006-1352","article-title":"Acute pediatric rhabdomyolysis: causes and rates of renal failure","volume":"118","author":"Rebekah","year":"2006;","journal-title":"Pediatrics"},{"issue":"2","key":"2020102716100116100_i1551-6776-16-3-216-b04","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981;","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2020102716100116100_i1551-6776-16-3-216-b05","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MAJ.0b013e31819e221f","article-title":"Rhabdomyolysis following clarithromycin monotherapy","volume":"338","author":"Brener","year":"2009;","journal-title":"Am J Med Sci"},{"issue":"4","key":"2020102716100116100_i1551-6776-16-3-216-b06","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","article-title":"Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin","volume":"50","author":"Westphal","year":"2000;","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"2020102716100116100_i1551-6776-16-3-216-b07","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1128\/AAC.01193-08","article-title":"Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration","volume":"53","author":"Khaled","year":"2009;","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2020102716100116100_i1551-6776-16-3-216-b08","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.amjcard.2006.08.051","article-title":"Safety and efficacy of statins in Asians","volume":"99","author":"Liao","year":"2007;","journal-title":"Am J Cardiol"},{"issue":"12","key":"2020102716100116100_i1551-6776-16-3-216-b09","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00228-004-0848-7","article-title":"Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients","volume":"60","author":"Wang","year":"2005;","journal-title":"Eur J Clin Pharmacol"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/16\/3\/216\/1785542\/1551-6776-16_3_216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/16\/3\/216\/1785542\/1551-6776-16_3_216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:29:55Z","timestamp":1738780195000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/16\/3\/article-p216.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-16.3.216","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}